Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Goldfinch Bio
Biotech
The 2023 Biotech Graveyard
Nearly four times as many companies entered the biotech graveyard in 2023 compared to 2022.
Max Bayer
,
Gabrielle Masson
Oct 31, 2023 6:00am
Karuna plunders Goldfinch's nest to pad neuroscience pipeline
Feb 2, 2023 8:16am
Goldfinch Bio has its wings clipped, shutting down after 7 years
Jan 27, 2023 1:20pm
Goldfinch's kidney drug one-one in early phase 2 data
Feb 28, 2022 10:15am
Ex-FDA head Hahn now CEO of Harbinger Health—Chutes & Ladders
Dec 10, 2021 9:30am
Goldfinch nabs 13-year Ardelyx vet as CSO to advance kidney drug
Dec 6, 2021 10:30am